Treatment of pediatric refractory Crohn&rsquo;s disease with thalidomide

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 14, 2011; 17(10): 1286-1291
Published online Mar 14, 2011. doi: 10.3748/wjg.v17.i10.1286

Full Size Figure Download Figure

Figure 2 Endoscopy views of patients A, B, C, F before thalidomide treatment (A-D) and six months after thalidomide treatment (E-H).

Citation: Zheng CF, Xu JH, Huang Y, Leung YK. Treatment of pediatric refractory Crohn’s disease with thalidomide. World J Gastroenterol 2011; 17(10): 1286-1291
URL: https://www.wjgnet.com/1007-9327/full/v17/i10/1286.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i10.1286

Zheng CF, Xu JH, Huang Y, Leung YK. Treatment of pediatric refractory Crohn’s disease with thalidomide. World J Gastroenterol 2011; 17(10): 1286-1291 [PMID: 21455327 DOI: 10.3748/wjg.v17.i10.1286]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.